Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Keytruda
Tag: Keytruda
Evaxion enrols first patient in phase IIb melanoma study
3 October, 2022
Ultimovacs protects cancer vaccine technology until 2037
26 April, 2022
Capital injection sets Evaxion Biotech up for phase IIb trials
25 November, 2021
Evaxion Biotech to test EVX-01 in collaboration with Merck & Co.
29 October, 2021
New data gives weight to Ultimovacs’s cancer vaccine
20 May, 2021
Ultimovacs on track to develop universal cancer vaccine
24 September, 2020